Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Seth Oliveria

Neurological Surgery Portland, OR Medical Doctor

NPI 1922310622 CMS profile 930602

9155 Sw Barnes Rd Ste 440, Ste 440, Portland, OR 97225

Open in the dashboard

General payments

$96,918

204 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Seth Oliveria of Portland, OR is reported in the CMS Open Payments database as having received $96,918 across 204 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $48,176 64
2024 General $17,138 29
2023 General $11,188 28
2022 General $6,388 33
2021 General $11,163 14
2020 General $2,006 15
2019 General $859 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Seth Oliveria
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Seth Oliveria were reported at $48,176. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Seth Oliveria Neurological Surgery median Middle half National median
2019 $859 $582 $138–$3,006 $163
2020 $2,006 $294 $76–$2,174 $114
2021 $11,163 $387 $105–$2,432 $132
2022 $6,388 $542 $139–$2,989 $149
2023 $11,188 $534 $145–$2,697 $160
2024 $17,138 $574 $155–$3,046 $164
2025 $48,176 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $39,693 39 payments
  2. Medtronic, Inc. $33,750 74 payments
  3. Boston Scientific Corporation $14,529 45 payments
  4. BIOTRONIK NRO, Inc. $4,875 1 payment
  5. Medtronic USA, Inc. $2,431 29 payments
  6. NeuroPace, Inc. $728 5 payments
  7. Abbott Laboratories $425 6 payments
  8. Zap Surgical Systems, Inc. $264 1 payment
  9. Brainlab, Inc. $97 1 payment
  10. Elekta, Inc. $73 1 payment
  11. Other $53 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $67,175 22 payments
  2. Travel and Lodging $17,661 55 payments
  3. Food and Beverage $7,609 121 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,340 5 payments
  5. Grant $133 1 payment
Products named General payments · program years 2019–2025
  1. EXCELSIUS GPS $22,055 17 payments
  2. VISUALASE MRI-guided laser ablation $20,956 40 payments
  3. SABLE $10,450 2 payments
  4. Mazor X Stealth Edition $9,518 6 payments
  5. Prospera $4,904 2 payments
  6. Vercise $3,859 10 payments
  7. Excelsius Robotics System $3,280 2 payments
  8. ExcelsiusGPS Robotic Navigation System $3,000 1 payment
  9. VISUALASE MRI-guided laser ablation $1,971 11 payments
  10. PERCEPT PC BRAINSENSE $1,430 14 payments
  11. Other $6,543 78 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 55 billing codes

Paid by Medicare

$83,979

Medicare's payments for the services billed

Medicare patients

120

Average age 68

Services billed

255

64 women, 56 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 65%
Arthritis 50%
Depression 31%
Diabetes 25%
Ischemic heart disease 22%
Chronic kidney disease 18%
Cancer 16%
Heart failure 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

204 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record